461 related articles for article (PubMed ID: 24820261)
1. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
Mermelekas G; Zoidakis J
Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
[TBL] [Abstract][Full Text] [Related]
2. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
3. Advances in shotgun proteomics and the analysis of membrane proteomes.
Gilmore JM; Washburn MP
J Proteomics; 2010 Oct; 73(11):2078-91. PubMed ID: 20797458
[TBL] [Abstract][Full Text] [Related]
4. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
5. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
6. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.
Liu NQ; Dekker LJ; Stingl C; Güzel C; De Marchi T; Martens JW; Foekens JA; Luider TM; Umar A
J Proteome Res; 2013 Oct; 12(10):4627-41. PubMed ID: 23957277
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches to identify cold-regulated plasma membrane proteins.
Takahashi D; Nakayama T; Miki Y; Kawamura Y; Uemura M
Methods Mol Biol; 2014; 1166():159-70. PubMed ID: 24852635
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry.
Koutroukides TA; Jaros JA; Amess B; Martins-de-Souza D; Guest PC; Rahmoune H; Levin Y; Deery M; Charles PD; Hester S; Groen A; Christoforou A; Howard J; Bond N; Bahn S; Lilley KS
Methods Mol Biol; 2013; 1061():291-307. PubMed ID: 23963945
[TBL] [Abstract][Full Text] [Related]
10. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
11. Shotgun proteomics of plant plasma membrane and microdomain proteins using nano-LC-MS/MS.
Takahashi D; Li B; Nakayama T; Kawamura Y; Uemura M
Methods Mol Biol; 2014; 1072():481-98. PubMed ID: 24136542
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
Simpkins F; Czechowicz JA; Liotta L; Kohn EC
Pharmacogenomics; 2005 Sep; 6(6):647-53. PubMed ID: 16143004
[TBL] [Abstract][Full Text] [Related]
13. Large-scale proteomic analysis of membrane proteins.
Ahram M; Springer DL
Expert Rev Proteomics; 2004 Oct; 1(3):293-302. PubMed ID: 15966826
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry: uncovering the cancer proteome for diagnostics.
van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
[TBL] [Abstract][Full Text] [Related]
15. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
16. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.
Wang H; Hanash S
Methods; 2015 Jun; 81():34-40. PubMed ID: 25794949
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.
André M; Le Caer JP; Greco C; Planchon S; El Nemer W; Boucheix C; Rubinstein E; Chamot-Rooke J; Le Naour F
Proteomics; 2006 Mar; 6(5):1437-49. PubMed ID: 16404722
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
